Harry R Haynes

6PUBLICATIONS
9CO-AUTHORS
Haematological tumoursMolecular targetsLiquid biopsiesTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2021
Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding.

Harry R Haynes, Vivek Mohan, Behrang Mozayani

|Jan 04, 2021
A report of a patient presenting with three metachronous 13q14LOH mesenchymal tumours: spindle cell lipoma, cellular angiofibroma and mammary myofibroblastoma.

Andrea Cordaro, Harry R Haynes, Timothy Murigu

|Mar 05, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua

|Nov 05, 2019
Diathermy-assisted axillary sentinel lymph node biopsy for breast carcinoma risks understaging the axilla in over a quarter of cases.

Tatiana Bovill Rose, Harry R Haynes, Richard J Sutton

|Sep 21, 2019
Synchronous small lymphocytic lymphoma and metastatic breast carcinoma in axillary lymph nodes: Preservation of follicular architecture only in the portions of affected lymph nodes involved by metastatic carcinoma.

Harry R Haynes, D Simon C Rose

|Dec 20, 2018
shRNA-mediated PPARĪ± knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.

Harry R Haynes, Helen L Scott, Clare L Killick-Cole

Pageof 1

Frequent Collaborators

1 joint publications

Paula I Gonzalez-Ericsson

1 joint publications

Ian Cree

1 joint publications

Marcelo Balancin

1 joint publications

Anna Ehinger